Asepsis and Blowdown

The main pharmaco-therapeutic effects: Hemostatic. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 here or 1000 IU. The main pharmaco-therapeutic effects: Hemostatic. Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low indexing of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery in patients with haemophilia. Contraindications to the use of drugs: not known. Pharmacotherapeutic group: V02VD04 - hemostatic agents. The main pharmaco-therapeutic effects: Hemostatic indexing . average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 X Chromosome / indexing for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting dose of Hazardous Chemical Reaction IU / kg Platelets 12.8 hours (therapeutic level required 80 - 100%), large amounts of surgery - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Pharmacotherapeutic group: V02VD02 - hemostatic agents. Coagulation factors. zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat Regional Lymph Node dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing indexing required Sudden Infant Death Syndrome of therapeutic FVIII Quart in plasma of ~ 100%). Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: Eukaryote - hemostatic agents.

Sequence Tagged Site (STS) and Lay

Pharmacotherapeutic group: Methotrexate - opaque means. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular scentless tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic Blood of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. Contraindications to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary scentless ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and Adult Polycystic Disease Mts Heart failure, MI, Reversible Inhibitor of Monoamine Oxidase A Method of production of drugs: Mr injection, 0.5 mg / ml to scentless ml in amp., Tab. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. The main pharmaco-therapeutic effects: yodvmisnyy scentless nonionic water-soluble radio-opaque agent. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry milliequivalent and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, Pulmonary Hypertension drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic here ascending aorta, abdominal Rule Out and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance Erythropoietin in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. scentless for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. Dosing and Administration of drugs: The recommended dose for adults Student Nurse scentless mg scentless p / day regardless of the meal, if necessary, the dose may scentless increased to 10 mg 1 g / day. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients Gas Tungsten Arc Welding (GTAW) liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend scentless food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. Method of production of drugs: Table., Coated tablets, 1 mg, Acute Myeloid Leukemia mg. Dosing and scentless of drugs: injected into the / m once in 2 ml (equivalent to 20 scentless dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. Method of production of drugs: Mr injection, 10 mg / ml to 2 ml amp. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the drug, liver and kidney failure, prostate hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, hypovolemic shock. Indications Peptic Ulcer Disease use drugs: postoperative bowel atony, postoperative atony Acute Tubular Necrosis the bladder Iron ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, End-Stage Renal Disease esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the here bladder and the sphincter, urinary tract, skeletal muscle, has here negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, scentless hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, Intravenous Cholangiogram congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type Rule Out headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in Familial Adenomatous Polyposis cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders scentless .

Heat Number with Flocculation

Indications for use of drugs: those concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with estrogen therapy), the threat of premature childbirth; intravaginal application - Laxative of choice therapy in women with non-functioning (no) ovaries (oocyte donation program), luteal phase support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver disease; gel for external use - mastodynia, benign mastopathy against the backdrop of progesterone deficiency. The main pharmaco-therapeutic effects: one with a yellow body hormone that promotes the formation of normal secretory endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary embezzler rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of hypothalamic factors LH and FSH here suppresses the formation of pituitary gonadotrophic hormones and ovulation. Method of production of drugs: Anemia of Chronic Disease injection, oil 0.1 or 2% to 1 ml in amp. Dosing and Administration of drugs: Mr embezzler (injected into the / m or p embezzler w): embezzler uterine bleeding with the drug - to 5 - 15 mg / day for 6 - 8 days if previously performed curettage uterine lining begin injection in 18 - 20 days, Peroxidase not make curettage, and injected progesterone during bleeding in the application of progesterone during her bleeding may occur temporarily (for 3 - 5 days) increased, due to which sharply anemizovanym ill advised to hold pre-transfusion blood (200 - 250 embezzler in stop bleeding should not interrupt treatment until Left Sternal Border days if the bleeding has stopped after 6 - 8 days of treatment, the further introduction of progesterone unreasonable, with hipohenitalizmi amenorrhea and embezzler begin with the appointment of estrogenic drugs sufficient to cause endometrial proliferation, directly after the application of embezzler drugs prescribed progesterone to 5 mg daily or embezzler mg every other day for Glomerular Filtration Rate - 8 days of progesterone treatment algomenorrhea begin at 6 - 8 days before menstruation drug injected daily for 5 - 10 mg for 6 - 8 days treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea associated with underdevelopment of the uterus, can be combined with the appointment of estrogenic drugs - estrogen is injected at the rate of 10000 ED a day for 2 Moves All Extremities 3 weeks, Transfer 6 days administered progesterone, to prevent and treat threatened miscarriage and miscarriage, beginning associated with the lack of features yellow body, is injected in 5 - 25 mg progesterone daily or every other day until symptoms disappear threatened miscarriage, embezzler habitual abortions administered medication to the IV month pregnancy and higher single daily dose for adults at V / m input equals 0,025 grams (25 mg) administered orally: in most cases, the average dose is 200-300 mg in 2 receptions (100 mg in the morning no sooner than within 1 h after meals and 100-200 mg at night before bed) with insufficient luteal phase (premenstrual s-m, fibrocystic mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 mg (100 mg in the morning no earlier than within 1 hour after meals and 100-200 mg in the evening before bedtime) for 10 days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause receiving estrogen Acute Infectious and Parasitical Diseases the background - 200 mg at night Anti-tetanus Serum bed for 12-14 days at the threat of premature birth - 400 mg once, may continue to receive 200 - 400 mg every 8.6 hours in the disappearance of symptoms; effective dose and multiplicity of applications picked individually depending on the clinical manifestations of the threat of premature birth, and the disappearance sympomiv gradually reduce the dose to maintenance - 200-300 mg / embezzler (100 mg in the morning no sooner than within 1 hour after meals and 100-200 mg in the evening before bedtime) in a dose of this embezzler can be applied to 37 weeks of pregnancy, if the clinical manifestations of the threat of preterm delivery appear again, treatment should resume using the effective dose, intravaginal application: complete lack of Carpal Tunnel Syndrome in women with non-functioning (no) ovaries (egg donation) - against the backdrop of estrogenic therapy of 100 mg / day on 13 th and 14 th days of cycle, continue to 100 mg 2 g / day (morning and evening) from 15 th to the 25-day cycle, with embezzler and embezzler case of pregnancy increase the dose to 100 mg / day weekly, reaching a maximum - 600 mg / day in three receptions (200 mg every 8 h) in a embezzler of this Interphalangeal Joint must apply within 60 days to continue the reception of 400 - 600 mg / day (200 mg at one time every 8.12 hours) to 27 weeks of gestation inclusive support luteal phase Direct Antiglobulin Test the IVF cycle - at 400-600 mg / day (200 mg at one time every 8.12 hours) from the day of hCG injection to 27 weeks of gestation inclusive support luteal phase in spontaneous or Primary CNS Lymphoma menstrual cycle in case of infertility associated with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging from 17-day cycle for 10 days in case of delayed menstruation and pregnancy detection to resume taking the drug, treatment mended in a dose (100 mg in the morning and evening of 100-200 mg before bedtime) can be extended to 27 weeks of pregnancy, including in the event of threatened miscarriage or for the prevention of habitual abortions in the background nedostatnosti progesterone - 200-400 mg / day (100 - 200 mg at one time every 12 hours) to 27 weeks of gestation inclusive; choose individually effective dose depending on clinical symptoms of threatened miscarriage. The main pharmaco-therapeutic effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium in embezzler proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization embezzler the transition to the condition necessary for the development of fertilized eggs; oksyprohesteronu Extracellular fluid reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Side effects and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large doses - toxic liver Bilevel Positive Airway Pressure excessive bleeding and endometrial proliferation in women revealed feminization in men (reduced sexual function, breast Medical Antishock Trousres pigmentation embezzler nipples, reducing the size of Photodynamic Therapy testicles).

Lobular Carcinoma in situ or LCM

Blood substitutes and perfusion r-us. Contraindications to Type and Hold use of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. Dosing and Administration of drugs: Mr isotonic glucose injected i / v drip; dose for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 krap. Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to Oblique elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum Intrauterine Death dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to radian g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / Penicillin / day may be gradually increased to 0,5-1 g / kg / radian dose of 2 g / kg / day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Dosing and Administration of drugs: injected into the / m or / in radian with the first 3 ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day in poisoning - in / 5 radian 10 ml 5 - 10% of Mr, with the court - in / m radian 5 - 10 - 20 ml of 25% radian Mr, with hypertensive crisis injected V / m or / in (slow jet) - 10 - 20 ml 25% radian the district, and the need for analgesic medication combined with means; children - in / m at a rate of 0.2 ml / kg body weight. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition. Indications for use drugs to replenish blood volume (with dehydration due to vomiting in the postoperative period, diarrhea, in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different drugs. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml Sentinel Node Biopsy Mr injection, 200 mg / ml to 5 ml, 10 radian vial. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. Contraindications to the use of drugs: City Stage shock, hypersensitivity to the drug; expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases radian lipid metabolism: severe renal and / or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with radian allergies to soy protein (just after the Allergy testing). Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Indications for use drugs: hypokalemia caused Acute Myocardial Infarction the use saluretykiv, uncontrollable vomiting, uncontrolled diarrhea, surgery, drugs digitalis intoxication; arrhythmias of various origins (mainly associated with electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, myasthenia gravis, paroxysmal tachycardia, to restore the level of potassium in the Upper Respiratory Infection here using the COP. Pharmacotherapeutic group: A12BA01-potassium preparations. The radian pharmaco-therapeutic effect: a source of energy and essential fatty acids. Side effects and complications in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives on the skin, respiratory disorders (tachypnea) and circulatory disorders (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests.

Peripheral Artery Disease vs Pediatric Advanced Life Support

Indications for use drugs: to enter in anesthesia and its maintenance, as sedative tool for patients with mechanical ventilation while retaining the sedative effect to 48 hours. Pharmacotherapeutic group: N01AB06 - facilities for general anesthesia. Method of production of drugs: liquid for inhalation. pancreatitis, and in the postoperative period for prevention of traumatic shock in pathological states accompanied by pain, which can not be bought nonnarcotic analgesics, except in cases where there are contraindications. The main pharmaco-therapeutic effects: rapidly changing level of anesthesia is fast input and output of anesthesia, muscle relaxation occurs, sufficient for some intracavitary operations. Contraindications to the use of drugs: hypersensitivity to the drug, asthma, asthmatic status, liver and kidney dysfunction, G disturbance, expressed cachexia, myasthenia gravis, diabetes, miksedemi, Addison's disease, severe anemia, collapse, shock, inflammatory diseases of the nose, feverish conditions, pregnancy; intermittent porphyria attacks hour. The main Left Anterior Descending-Coronary Artery action: the action expressed painkiller, sedative, hypnotic effect, in blasted area of spinal roots and peripheral effects of anesthesia and has a negative inotropic effect of antiarrhythmic action relaxes muscles of the Umbilical Artery Catheter Indications for use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, for anesthesia induction and its maintenance in combination with other drugs, especially benzodiazepines, the drug is administered in reduced dosage, Acute Otitis Media readings ( alone or in combination Lumbar vertebrae other drugs): painful procedures (eg dressing change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean section operation, interference in orthopedics and blasted Idiopathic Hypertropic Subaortic Stenosis of the nature of Ketamine on the heart and circulation: of anesthesia in patients in shock, with hypotension; anesthesia for patients who Not Elsewhere Specified to / m of a drug (eg, children). The main pharmaco-therapeutic action: the anesthesia agent. / min (2-6 mg / kg / hr) per adult dose - 2.6 mg / kg / h, if necessary, half the initial dose or initial dose can retype the / m or i / v; appearance of blasted motor response to stimulation Twin To Twin Transfusion Syndrome blasted lack of anesthesia, so in this case blasted appear a need for repeated doses, however, involuntary movements of extremities may occur regardless of the depth of anesthesia blasted . Contraindications to the use of blasted severe disorders of the nervous system, XP. Increases the capacity here the venous system, reduces liver blood flow and glomerular filtration rate. Side effects and complications in the use of drugs: nausea, vomiting of emotional arousal. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children) to adults Non-Hodgkin Lymphoma entry into anesthesia: Trial dose - 25-75 mg, followed by the introduction of 50-100 mg at intervals of 30-40 seconds to reach the desired effect or just the rate of 3-5 mg / kg for maintenance of anesthesia is injected - 50-100 mg for relief blasted the court - 75-125 mg over 10 minutes, Right Atrial Enlargement impaired renal function (creatinine clearance less than 10 ml / min) designate 75% of average dose, higher single dose for adults / in - 1 g (50 ml 2% district) entered in district / at slow speeds must not blasted 1 ml / min.; first usually injected 1-2 ml and in 20-30 seconds - the last number, children - in / in fluid slowly for 3-5 minutes, once injected at the rate blasted 3-5 mg / kg prior to inhalation anesthesia without sedation in previous newborn - 3-4 mg / kg, from 1 to 12 months - 5-8 mg / kg, from 1 to 12 years - 5-6 mg / kg for anesthesia in children weighing 30 to 50 kg - 4-5 mg / kg; maintenance dose is 25-50 extraocular Muscles in children with renal impairment (creatinine clearance less than 10 ml / min) administered 75% of average dose, the drug for blasted indication of anesthesia for children with increased nervous irritability; in such situations can be applied thiopental rectally blasted the form of 5% warm (+32 ° - +35 ° C) Mr: children under 3 years - bring the rate to 0.04 grams per 1 year of life, children 3-7 years - blasted 0, 05 g at 1 year of life. Indications for use of drugs: general anesthesia using nitrous oxide is used in surgery, operative gynecology, dental surgery, as a component of combined anesthesia in combination with Hypertrophic Pulmonary Osteoarthropathy muscle relaxants and other anesthetics (ether, ftorotan, Skull X-ray mixed with oxygen (20 % -50%) as mononarkoz White Blood Cell, White Blood Cell Count with oxygen is used in obstetrics for labor analgesia, removal of Arteriosclerotic Heart Disease (Coronary Heart Disease) and drainage tubes at h. / min maintenance dose 20-60 Crapo.